Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Liechti

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Emergency Medicine Journal : EMJ|April 10, 2010
Effects of a beta-blocker on the cardiovascular response to MDMA (Ecstasy)C M Hysek, F X Vollenweider, M E Liechti
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 27, 2003
Clostridium septicum aortitis in a patient with colon carcinomaM E Liechti, O Schöb, G M Kacl, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 25, 2000
Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopramM E Liechti, C Baumann, A Gamma, et al.
Praxis|February 19, 2009
[Renal failure and hemolytic anemia. Rifampicin associated interstitial nephropathy with immune hemolytic anemia]M Bodmer, M Haschke, A E Rätz Bravo, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 13, 2001
Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserinM E Liechti, M A Geyer, D Hell, et al.
Neuropharmacology|November 27, 2013
Monoamine transporter and receptor interaction profiles of a new series of designer cathinonesL D Simmler, A Rickli, M C Hoener, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 26, 2003
Plasmodium falciparum cerebral malaria complicated by disseminated intravascular coagulation and symmetrical peripheral gangrene: case report and reviewM E Liechti, V Zumsteg, C F R Hatz, et al.
Praxis|August 3, 2002
[Pneumomediastinum after tooth extraction]M E Liechti, B Nyfeler, E Achermann, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 16, 2000
Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humansM E Liechti, M R Saur, A Gamma, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 16, 2000
3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humansA Gamma, A Buck, T Berthold, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Emergency Medicine Journal : EMJ|April 10, 2010
Effects of a beta-blocker on the cardiovascular response to MDMA (Ecstasy)C M Hysek, F X Vollenweider, M E Liechti
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 27, 2003
Clostridium septicum aortitis in a patient with colon carcinomaM E Liechti, O Schöb, G M Kacl, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 25, 2000
Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopramM E Liechti, C Baumann, A Gamma, et al.
Praxis|February 19, 2009
[Renal failure and hemolytic anemia. Rifampicin associated interstitial nephropathy with immune hemolytic anemia]M Bodmer, M Haschke, A E Rätz Bravo, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 13, 2001
Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserinM E Liechti, M A Geyer, D Hell, et al.
Neuropharmacology|November 27, 2013
Monoamine transporter and receptor interaction profiles of a new series of designer cathinonesL D Simmler, A Rickli, M C Hoener, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 26, 2003
Plasmodium falciparum cerebral malaria complicated by disseminated intravascular coagulation and symmetrical peripheral gangrene: case report and reviewM E Liechti, V Zumsteg, C F R Hatz, et al.
Praxis|August 3, 2002
[Pneumomediastinum after tooth extraction]M E Liechti, B Nyfeler, E Achermann, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 16, 2000
Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humansM E Liechti, M R Saur, A Gamma, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 16, 2000
3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humansA Gamma, A Buck, T Berthold, et al.
Pageof 3